1. Memori
  2. ›
  3. Articles

Molluscum Contagiosum: Should You Treat It? — What the Meta-Analysis Actually Shows

By Leon MoriguchiPublished May 15, 2026Updated May 18, 20264 min read日本語版あり
Audience
Parents uncertain about treatment for their child's molluscum; parents told by daycare to keep their child out of the pool

TL;DR

  • ·Molluscum contagiosum is a genuinely self-limiting condition: in a UK cohort, lesions took about 13 months on average to clear, about 70% had resolved by 18 months, and about 13% were still present at two years — the tradeoff for waiting is mostly time, not outcome
  • ·A 2017 Cochrane review found insufficient evidence that any active treatment is meaningfully superior to watchful waiting once the harms of treatment — pain, scarring, procedural distress — are factored into the comparison
  • ·Pool exclusion of children with molluscum has no adequate medical basis; a joint statement from Japan's three dermatology societies (including the Japanese Society of Pediatric Dermatology) says children with molluscum may use the pool, asking only that towels and kickboards not be shared, and the School Health Safety Act does not list it as a reason for exclusion

Contents

  1. Lead
  2. What Molluscum Contagiosum Is
  3. The Reality of Natural Resolution
  4. What the Evidence Says About Treatment
  5. Daycare and School Policies
  6. When Choosing Not to Treat Is the Right Call
  7. Summary
  8. References

Lead

The daycare said the pool is off-limits until the molluscum clears up. The dermatologist suggested removing them, but the procedure looked painful. And somewhere along the way you heard that they just go away on their own.

This article lays out the two options — treat or wait — against what the evidence actually says about molluscum contagiosum (water warts).

What Molluscum Contagiosum Is

Molluscum contagiosum is a skin infection caused by the molluscum contagiosum virus (MCV), a member of the poxvirus: family of large double-stranded DNA viruses that replicate in the cell's cytoplasm and cause characteristic skin lesions family. It produces small, pearly papules: small, firm, raised bumps on the skin surface, less than 1 cm wide — typically 2–5 mm in diameter — scattered across the trunk, limbs, and face. In children with a competent immune system, it is a benign condition that resolves on its own.

A systematic review estimated the point prevalence (the share of children who have it at any given time) at about 5–12% among children aged 0–16, with new cases most common at ages 1–4 [2]. The virus spreads through direct skin-to-skin contact and indirectly via shared towels and play equipment.

The Reality of Natural Resolution

Molluscum is widely described as self-limiting — but "self-limiting" takes time. A UK prospective cohort study that followed 306 children with molluscum monthly found a mean time to resolution of about 13 months; about 70% had cleared spontaneously by 18 months, but about 13% still had lesions at 24 months [6]. In other words, natural resolution happens, but over one to two years rather than a few weeks, and in some children it takes longer than two years.

During that waiting period, the number of lesions may increase — a common occurrence during the natural course. In children with atopic dermatitis, molluscum can trigger eczema flares [3]. That said, widespread or severe disease in immunocompetent children is rare.

What the Evidence Says About Treatment

The main treatments used in practice are:

  • Mechanical removal (curettage): the most widely used, but involves pain and procedural distress for the child
  • Silver nitrate paste or liquid nitrogen: chemical or cryotherapy approaches
  • Cantharidin: a toxic compound from blister beetles that destroys the top skin layer, causing blistering and lesion removal (a blistering agent derived from blister beetles): not covered by insurance in Japan; used in some other countries
  • Imiquimod cream: an immune-response modifier: topical drug that activates the body's own immune system to attack virus-infected skin cells; mainly used in treatment-resistant cases

A Canadian randomized trial comparing four treatments in 124 children aged 1–18 found that curettage (scraping the lesions off) most often cleared them in a single visit and had the fewest side effects, but it required adequate anesthesia and was time-consuming. Cantharidin caused more blister-related side effects and needed more visits [4].

The 2017 Cochrane systematic review evaluated these approaches comprehensively. Its conclusion: there is currently insufficient evidence that active treatment is significantly superior to watchful waiting [1]. When the harms — pain, scarring, procedural anxiety — are factored in, the trade-offs for most treatments are not clear.

There are situations where treatment becomes a reasonable conversation with a physician: rapidly increasing lesion count, worsening atopic dermatitis, or clear transmission to a sibling or contact with eczema. But these are contextual decisions rather than defaults.

Daycare and School Policies

In Japan, a persistent practice in some facilities has been to prohibit children with molluscum from using the pool. However, a joint statement from the Japanese Society of Clinical Dermatologists, the Japanese Society of Pediatric Dermatology, and the Japanese Dermatological Association says that molluscum is not spread through pool water, so children with it may swim. It adds that the virus can spread via towels, swim rings, and kickboards, so these should not be shared where possible, and that children should shower after swimming [5].

Molluscum contagiosum is also not listed under the School Health Safety Act as a disease requiring exclusion from attendance. The primary route of transmission is skin contact and shared towels — not pool water itself — so there is little medical basis for banning pool use.

When a daycare or school imposes swimming or attendance restrictions, parents have a practical option: bring the societies' statement to a conversation with the facility. Asking a physician to write a brief explanatory note for the school is also done in practice.

When Choosing Not to Treat Is the Right Call

Given the Cochrane review's conclusions, choosing not to treat is a medically grounded option. The following situations are ones where waiting may spare the child unnecessary discomfort:

  • The child is young and difficult to keep still during procedures
  • The child has strong fear of pain, and a difficult clinical experience could affect future willingness to seek care
  • The number of lesions is small and there is no sign of increase

Choosing to treat is also not irrational. Facility rules, a sharp rise in lesion count, or a parent's own anxiety about waiting are all legitimate motivations. Treatment options exist and can be discussed with a physician.

What matters is not which choice is "correct" but rather making a decision that fits the child's specific situation — informed by where the evidence actually stands.

Summary

Molluscum contagiosum is a benign, self-limiting condition, and strong evidence that active treatment outperforms watchful waiting does not currently exist. The treatment decision depends on the child's age, pain tolerance, facility policies, and family preferences. The evidence base for pool exclusion is thin. Having a grasp of these facts changes the quality of the conversation you can have at the clinic.

References

  1. van der Wouden JC, van der Sande R, Kruithof EJ, Sollie A, van Suijlekom-Smit LW, Koning S. Interventions for cutaneous molluscum contagiosum. Cochrane Database Syst Rev. 2017;5(5):CD004767. doi:10.1002/14651858.CD004767.pub4. PMID: 28513067.
  2. Olsen JR, Gallacher J, Piguet V, Francis NA. Epidemiology of molluscum contagiosum in children: a systematic review. Fam Pract. 2014;31(2):130–136. doi:10.1093/fampra/cmt075. PMID: 24297468.
  3. Silverberg NB. Molluscum contagiosum virus infection can trigger atopic dermatitis disease onset or flare. Cutis. 2018;102(3):191–194. PMID: 30372710.
  4. Hanna D, Hatami A, Powell J, et al. A prospective randomized trial comparing the efficacy and adverse effects of four recognized treatments of molluscum contagiosum in children. Pediatr Dermatol. 2006;23(6):574–579. doi:10.1111/j.1525-1470.2006.00313.x. PMID: 17156002.
  5. Japanese Society of Clinical Dermatologists, Japanese Society of Pediatric Dermatology, Japanese Dermatological Association. Unified statement on skin infections at school and swimming pools [in Japanese: 皮膚の学校感染症とプールに関する統一見解]. May 2015. https://www.dermatol.or.jp/uploads/uploads/files/news/G20160519_20130524_01.pdf
  6. Olsen JR, Gallacher J, Finlay AY, Piguet V, Francis NA. Time to resolution and effect on quality of life of molluscum contagiosum in children in the UK: a prospective community cohort study. Lancet Infect Dis. 2015;15(2):190–195. doi:10.1016/S1473-3099(14)71053-9. PMID: 25541478.

In the memori app

The memori app keeps the course of a sick day in a form you can hand straight to a clinician.

  • Temperature and symptoms line up on one timeline: when it started, and how it moved.
  • Medicines are laid out by dose time, so a missed one is visible.
  • You can jot down what you want to ask before the appointment.
Try memori
← PreviousBefore the Baby Gets Whooping Cough — The Cocooning Strategy and Booster Vaccination for FamiliesNext →Stopping Impetigo from Spreading — Evidence on Antibiotics and Household Infection Control

Related

  • Early Education: What the Evidence Actually Shows
  • Does Reading Aloud Actually Work? Calibrating the Evidence
  • Baby Signs: What the Meta-Analyses Actually Say